What are the recommended doses of Augmentin (amoxicillin-clavulanic acid) for treating urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Doses of Augmentin (Amoxicillin-Clavulanic Acid) for UTIs

For urinary tract infections (UTIs), Augmentin (amoxicillin-clavulanic acid) should be dosed at 375 mg three times daily for 7 days in uncomplicated cases, and for 7-14 days in complicated UTIs. 1

Dosing Recommendations Based on UTI Classification

Uncomplicated UTIs

  • 375 mg three times daily (250 mg amoxicillin plus 125 mg clavulanic acid per tablet) for 7 days 2
  • Microbiological cure rates of approximately 84% one week after treatment completion 2

Complicated UTIs

  • 375 mg three times daily for 7-14 days 3
  • Longer duration (10-14 days) recommended for patients with delayed response 3
  • All male UTIs are considered complicated and require the longer treatment duration 4

Recurrent UTIs

  • Initial treatment: 375 mg three times daily for 7 days 2
  • Microbiological cure rates of 67% at one month post-treatment 2
  • Consider prophylactic regimens for frequent recurrences 3

Special Populations

Pediatric Dosing

  • Initial treatment: 40 mg/kg/day divided into two doses for 5 days 5
  • For recurrent UTIs: After initial treatment, 20 mg/kg once daily (evening dose) for prophylaxis 6, 5
  • Pediatric formulations should be used for appropriate weight-based dosing 5

Renal Impairment

  • Dose adjustment required based on creatinine clearance 3
  • For patients with severe renal impairment (creatinine clearance <10 mL/min), consider alternative agents or reduced dosing frequency 3

Clinical Considerations

Duration of Therapy

  • 7 days is recommended for patients with prompt symptom resolution 3
  • 10-14 days for patients with delayed response 3
  • Catheter-associated UTIs typically require the full 7-14 day course regardless of catheter removal 3

Antimicrobial Resistance Considerations

  • Augmentin is particularly valuable for treating UTIs caused by amoxicillin-resistant organisms 1
  • The addition of clavulanic acid reduces resistance in most Gram-negative urinary pathogens 1
  • Success rates of approximately 70% have been reported for amoxicillin-resistant organisms 1

Alternative Regimens When Augmentin Is Not Appropriate

  • For multidrug-resistant organisms, consider newer agents like ceftazidime-avibactam, meropenem-vaborbactam, or imipenem-cilastatin-relebactam 3
  • Fluoroquinolones (if local resistance is low) or trimethoprim-sulfamethoxazole may be alternatives 4
  • Single-dose aminoglycoside therapy may be considered for simple cystitis due to resistant organisms 3

Monitoring and Follow-up

  • Obtain urine culture before initiating therapy 4
  • Monitor for common side effects, which occur in approximately 20% of patients but are generally mild 2
  • Gastrointestinal side effects can be minimized by taking medication with food 5
  • Consider follow-up cultures after completion of therapy to confirm eradication in complicated cases 4

Common Pitfalls and Caveats

  • Failure of therapy may indicate underlying anatomical abnormalities requiring further investigation 7
  • Taking medication with food can reduce gastrointestinal side effects without significantly affecting efficacy 2
  • For patients experiencing vomiting with twice-daily dosing, consider switching to three times daily dosing at a lower individual dose 5
  • Always verify local resistance patterns before empiric therapy, as resistance rates to amoxicillin-clavulanate vary by region 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.